{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-025521","form_type":"8-K","ticker":"VTAK","cik":"0001716621","company_name":"Catheter Precision, Inc.","filed_at":"2022-07-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.765172+00:00","generated_at":"2026-06-24T18:33:55.600039+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Ra Medical appoints CEO as interim CFO; gets FDA clearance but won't sell DABRA 2.0","bullets":["Jonathan Will McGuire, current CEO, appointed interim CFO effective July 8, 2022; no extra compensation.","FDA 510(k) clearance granted for DABRA 2.0 catheter on July 5, 2022.","Company states it has no plans to commercialize the DABRA 2.0 catheter.","Board continues strategic alternatives review; in June 2022 cut workforce by ~65% to preserve capital."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-025521","json":"https://secwatch.observer/filing/0001564590-22-025521.json","markdown":"https://secwatch.observer/filing/0001564590-22-025521.md","text":"https://secwatch.observer/filing/0001564590-22-025521.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716621/000156459022025521/0001564590-22-025521-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716621/000156459022025521/rmed-8k_20220708.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T18:33:55.600039+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"55f3638e44","claim":"Jonathan Will McGuire was appointed as interim Chief Financial Officer at Catheter Precision, Inc..","evidence_excerpt":"On July 8, 2022, the board of directors of the Company appointed Jonathan Will McGuire to act as interim Chief Financial Officer effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1716621/000156459022025521/0001564590-22-025521-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"interim Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}